Advertisement
Affimed N.V.

Affimed N.V. (AFMDQ) Stock Overview

Explore Affimed N.V.’s financial performance, market position, analyst ratings, and future outlook.

AFMDQPNK
HealthcareBiotechnology
$0.00
$0.00(0.00%)
U.S. Market opens in 10h 40m
Advertisement

Affimed N.V. (AFMDQ)

Meyka AI Score

Z

Key Financials

Market Cap1.6K
P/E Ratio-0.00
EPS (TTM)$-5.24
ROE-1.01%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

AFMDQ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Affimed N.V. (AFMDQ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 1.6K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
0.00%
6-Month Change
0.00%
Year-to-Date (YTD) Change
0.00%
1-Year Change
-99.88%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

49 621 560030
Gottlieb-Daimler-Straße 2, Mannheim, NaN, 68165

Company Facts

76 Employees
IPO DateSep 12, 2014
CountryDE
Actively Trading

Frequently Asked Questions